Insmed
INSM
#540
Rank
HK$340.42 B
Marketcap
HK$1,596
Share price
-0.84%
Change (1 day)
172.09%
Change (1 year)

Operating Margin for Insmed (INSM)

Operating Margin as of December 2025 (TTM): -250.21%

According to Insmed's latest financial reports and stock price the company's current Operating Margin is -250.21%. At the end of 2024 the company had an Operating Margin of -250.22%.

Operating Margin history for Insmed from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-250.22%2.23%
2023-244.76%25.07%
2022-195.69%-15.49%
2021-231.57%30.08%
2020-178.02%-4.19%
2019-185.80%-94.36%
2018-3,295.13%
2013-498.21%
2011-1,350.78%1370.86%
2010-91.84%-108.02%
20091,145.54%-955.41%
2008-133.92%-50.67%
2007-271.47%-95.05%
2006-5,486.68%-73.8%
2005-20,941.98%4.61%
2004-20,018.25%183.65%
2003-7,057.33%278.86%
2002-1,862.76%-85.17%
2001-12,557.09%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Sarepta Therapeutics
SRPT
-10.44%-95.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
29.12%-111.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
33.98%-113.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
0.33%-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-10.86%-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
2.25%-100.90%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.